Showing 11-20 of 48 grants

Title Institution Researcher Program Duration Total Award Amount
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749,995.50
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes Minutia Katy Digovich Cures 01-November-2022 to 30-November-2025 $1,198,600.00
Effects of Volagidemab on Glucagon Rescue from Insulin-Induced Hypoglycemia REMD Biotherapeutics Dung Thai Improving Lives 30-June-2023 to 29-June-2026 $672,000.00
Inflammatory cytokines rewire the proinsulin interaction network in human islets Sanford-Burnham Medical Research Institute Pamela Itkin-Ansari Cures 01-May-2022 to 30-April-2025 $987,642.98
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943,983.20
Restoration of Treg function to prevent progression to hyperglycemia Stanford University C. Garrison Fathman Cures 01-June-2022 to 31-May-2025 $600,000.00
Development of Uni-molecular Glucose-responsive Insulin Stanford University Danny Hung-Chieh Chou Improving Lives 01-April-2022 to 31-March-2026 $749,998.34
Ultrafast Insulin-Pramlintide Co-formulations Stanford University Eric Appel Improving Lives 01-September-2022 to 31-August-2025 $795,000.00
Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants Stanford University Eric Appel Cures 01-January-2025 to 31-December-2026 $600,000.00
Endothelial cells for islet replacement in diabetes Stanford University Martin Neukam Cures 01-April-2024 to 31-March-2027 $251,600.00